A new study has identified commonly prescribed drugs for the treatment of hypertension may be capable of preventing Alzheimer's disease and cognitive deterioration.
A Mount Sinai Medical Center study has found that lower frequency deep brain stimulation in young patients with primary torsion dystonia is as effective as higher frequency stimulation, which has been commonly used.
The Mount Sinai Medical Center and New York City's Administration for Children's Services (ACS) have received a $2.4 million federal grant to establish the ACS-Mount Sinai Children's Trauma Institute.
Mount Sinai School of Medicine has just received a major grant from the National Center for Complementary and Alternative Medicine (NCCAM), a component of the National Institutes of Health (NIH) and lead Federal agency for research on complementary and alternative medicine.
Making statin treatment available without a prescription could help the fight against heart disease, says Valentin Fuster, MD, PhD, Director of Mount Sinai Heart and Director of the Zena and Michael A. Wiener Cardiovascular Institute and the Marie-Josée and Henry R. Kravis Center for Cardiovascular Health at The Mount Sinai Medical Center.
Mount Sinai is pleased to announce that after a lengthy and thorough national search, Dr. Kishore Iyer and Dr. Juan del Rio Martin have been promoted to the Surgical Directors of Pediatric and Adult Liver Transplantation. Over the last 6 months, Dr. Iyer and Dr. del Rio Martin have shown the institution that they have the skills and temperament to lead these programs to even higher levels of achievement.
How did a 250-year-old Jewish hospital located in the heart of Berlin, Germany, manage to survive during the Nazi regime? The answer to that question lies in a new traveling exhibit that is coming to The Mount Sinai Medical Center on October 1-19. To date, Mount Sinai is the only site in the United States to host this unique historical retrospective.
The Mount Sinai Medical Center's Head and Neck Cancer Center is teaming up with ENT and Allergy Associates, LLP to help fight cancer. The clinical alliance between Mount Sinai and ENT and Allergy Associates, the largest ear, nose and throat, allergy and audiology practice in the tri-state area, together will provide patients with a full spectrum of high quality care, cancer screening and advanced surgical options for patients diagnosed with cancer and other serious ENT conditions.
Researchers in the Department of Neuroscience at Mount Sinai School of Medicine have identified taste receptors in the human intestines. The taste receptor T1R3 and the taste G protein gustducin are critical to sweet taste in the tongue. Research now shows these two sweet-sensing proteins are also expressed in specialized taste cells of the gut where they sense glucose within the intestine.
The Centers for Disease Control and Prevention (CDC) has designated the Mount Sinai School of Medicine in New York City as its newest Injury Control Research Center (ICRC). The new center will conduct research on persons with traumatic brain injuries in order to better understand the consequences of their injury and to help enhance the quality of their lives.
A meta-analysis of four randomized Phase III placebo-controlled trials confirms that the injectable drug Efalizumab, a humanized therapeutic antibody designed to selectively and reversibly block the activation, reactivation and trafficking of T-cells that lead to the development of psoriasis, had an acceptable safety and efficacy profile in the treatment of psoriasis in heavy patients, researchers at Mount Sinai School of Medicine announced today.
A 32-year-old mother of two small children, who was recently diagnosed with metastatic stomach cancer, underwent surgery using Hyperthermic Intraperitoneal Chemotherapy at The Mount Sinai Medical Center. The surgery, which took place on Thursday, July 26th is a breakthrough in cancer treatment at Mount Sinai, giving a heated form of chemotherapy to the patients during surgery directly into the abdomen while in the operating room.
Cyclical, long-term estrogen injections protected brain cells from age-related deterioration, according to a new study conducted at Mount Sinai School of Medicine. The study suggests that age is a factor in estrogen treatment and sheds light on the intricate relationship between mind, age, and hormones.
Results from an international multi-center Phase II clinical trial suggest that extracorporeal photopheresis (ECP) may be effective in treating patients with clinically active (OR symptomatic) Crohn's disease who cannot tolerate or are refractory to immunosuppressants and/or anti-TNF agents.
The Mount Sinai Medical Center is the only hospital in New York City using the Novalis Shaped Beam Surgery System on spinal cancer. Novalis is the most advanced Stereotactic Radiosurgery(SRS) technology available to treat cancer tumors in the spine.
Leading scientists from prestigious institutions around the world will convene in New York to report on the remarkable progress of their cancer research projects. Their findings will be highlighted at this press conference.
The American Cancer Society and the National Palliative Care Research Center (NPCRC) are awarding $1.5 million in research grants to researchers at ten institutions for studies aimed at reducing suffering for seriously ill patients and their family caregivers. The studies will be conducted over the next two years.
How your food is cooked may be as important to your health as the food itself. Researchers now know more about a new class of toxins that might soon become as important a risk factor for heart disease and metabolic disorders as trans fats.
David B. Samadi, MD, one of the nation's leading urologic oncologists specializing in robotics and minimally invasive surgery for prostate cancer, has been named Chief of the Division of Robotics and Minimally Invasive Surgery in the Department of Urology at Mount Sinai.
Mount Sinai School of Medicine has been named to the first-ever President's Higher Education Community Service Honor Roll, an honor that recognizes students, faculty, and staff for building a culture of service and civic engagement. Mount Sinai was one of ten schools around the country"”and the only medical school"”to be recognized as a Community Service Finalist for Excellence in General Community Service.
A new imaging technology may hold the key to not only stopping heart attacks in their tracks but also preventing them for ever occurring. For the first time, researchers at Mount Sinai School of Medicine have shown the use multi-detector computed tomography (CT) imaging along with a novel contrast agent know as N1177 can detect dangerous, high-risk plaque which cause heart attack and stroke.
Philanthropic gift brings Mount Sinai Medical Center to the forefront of personalized medicine, an emerging field using information about a person's genetic make-up to customize strategies for the detection, treatment, and prevention of disease, by establishing the Bronfman Institute for Personalized Medicine.
A team lead by researchers at Mount Sinai School of Medicine, are the first to study outcomes in high cardiovascular risk patients with osteoarthritis. The researchers compared combination treatments of low-dose aspirin with the drugs ibuprofen, naproxen and the cox-2 inhibitor lumiracoxib. They have found that high cardiovascular risk patients taking ibuprofen and aspirin combined are nine times more likely suffer a heart attack.
John H. Morrison, PhD, Dean of Basic Sciences and the Graduate School of Biological Sciences of the Mount Sinai School of Medicine, has received a MERIT Award) from the National Institute on Aging (NIA), a division of the National Institutes of Health (NIH). A MERIT (Method to Extend Research in Time) Award is grant support from the NIH that honors a longstanding and distinguished record in scientific research and achievement.
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), announced today that Mount Sinai School of Medicine is a new Center of Excellence for Influenza Research and Surveillance. NIAID is awarding $23 million per year for seven years to establish six Centers of Excellence for Influenza Research and Surveillance around the country.
Kenneth L. Davis, MD, President and Chief Executive Officer of The Mount Sinai Medical Center, today announced the appointment of Dennis S. Charney, M.D., Dean of Mount Sinai School of Medicine and Executive Vice President for Academic Affairs of The Mount Sinai Medical Center. Dr. Davis had served as Dean of the School since 2003.
Mario Garcia, MD, a national expert in cardiac imaging, has been named Director of Non-Invasive Cardiology at Mount Sinai Heart.
Dr. Martignetti receives award from Prostate Cancer Foundation for work focusing on therapeutic role of siRNA in metastatic prostate cancer.
Researchers at Mount Sinai School of Medicine have just developed an advanced imaging technique to capture the movement of the microdomains of leukocytes or white blood cells.
Mount Sinai School of Medicine's PhD program ranked third among 53 institutions in a nationwide survey conducted by Academic Analytics.
A recent study by Mount Sinai School of Medicine (MSSM) finds children born with low birth weight (LBW) who suffered child abuse are more likely to develop psychological problems such as depression and social dysfunction in adolescence and adulthood. The study is the first to investigate the possible interaction between LBW and later adversity.
Modest changes in the 1918 flu virus's hemagglutinin receptor binding site"”a molecular structure critical for the spread of infection"”stopped viral transmission in ferrets, according to a new study conducted by researchers at Mount Sinai School of Medicine and at the Centers for Disease Control and Prevention.
A new study helps explain why psychedelic or hallucinogenic drugs like LSD produce unique and different effects in mood and behavior than their chemical cousins, such as lisuride, a treatment for Parkinson's disease.
Mount Sinai researchers have discovered a new potential diagnostic tool that could provide clinicians with a much-needed window into the molecular activity of blood vessels. The findings, which could help identify patients at risk for heart attack and stroke, were published in the January 16 issue of Proceedings of the National Academy of Sciences.
A normal heart beats 60 beats to 100 beats per minute (BPM). If the rhythm of the heart goes one beat over 100, a patient's life is in grave danger. This was the case for Jeffrey Nauser.
Mount Sinai School of Medicine and EXACT Sciences Corporation (NASDAQ: EXAS) announced today the publication of results from a prospective, multi-center study of stool DNA testing. The study found that the test demonstrated an 88% sensitivity for colorectal cancer, and with equal detection across all stages of cancer, regardless of the cancer's location in the colon. The study was published online in the American Gastroenterological Association's journal, Clinical Gastroenterology and Hepatology, and will appear in the January 2007 print issue.
The Mount Sinai will honor Douglas Lowy, Laboratory Chief and Principal Investigator, Laboratory of Cellular Oncology, Division of Basic Sciences, National Cancer Institute, NIH and John Schiller, Deputy Chief and Principal Investigator, Laboratory of Cellular Oncology, Division of Basic Sciences, National Cancer Institute, NIH, for research contributions which led to the clinical development of the Human Papillomavirus (HPV) vaccine against cervical cancer.
Amniocentesis is the most commonly prescribed invasive test performed during pregnancies in the United States. Researchers at Mount School of Medicine in conjunction with other institutions in the FASTER trial report that pregnancy miscarriage rates after routine midtrimester amniocentesis are significantly lower than rates previously published years ago in the 1970s and 1980s- 0.5% or 1 in 200 pregnancies.
The Office of the US Attorney General announced today The Mount Sinai Medical Center will be one of five recipients of a prescription drug education grant for health care professionals. The $400,000 grant is funded by the Attorney General Consumer and Prescriber Education Grant Program and will be used to educate physicians and medical students about pharmaceutical company marketing practices and promote evidence-based prescribing practices.
The National Palliative Care Research Center, Mount Sinai School of Medicine, has been awarded a $5 million grant from the National Cancer Institute (NCI) of the National Institutes of Health (NIH).
The Mount Sinai Medical Center and The Samuel Waxman Cancer Research Foundation honor the NIH scientists who helped develop FDA-approved cervical cancer vaccine. More than 150 distinguished guests and eminent physicians will host an award lecture recognizing the two NIH scientists whose research resulted in the clinical development of the Human Papillomavirus (HPV) vaccine against cervical cancer.
A recent study directed by Mount Sinai School of Medicine (MSSM) suggests that seniors with low incomes or no prescription coverage were less likely to use generic cardiovascular drugs than more affluent seniors and those with prescription drug coverage.
After Hurricane Katrina, there has been a nationwide emphasis on getting emergency preparedness information to residents in coastal areas. New York City is no exception. Researchers have just reported that the Costal Storm Plan (CSP) and Geographic Information System (GIS) Map are unclear to certain target populations.
An analysis of mice infected with the reconstructed 1918 influenza virus has revealed that although the infection triggered a very strong immune system response, the response failed to protect the animals from severe lung disease and death.
A new study directed by Mount Sinai School of Medicine has found that moderate red wine consumption in a form of Cabernet Sauvignon may help reduce the incidence of Alzheimer's Disease (AD).
A new study directed by Mount Sinai School of Medicine extends and strengthens the research that experimental dietary regimens might halt or even reverse symptoms of Alzheimer's Disease (AD). Restricting caloric intake may prevent AD by triggering activity in the brain associated with longevity.
The National Education Alliance for Borderline Personality Disorder (NEA-BPD), the Department of Psychiatry, Mount Sinai School of Medicine, and the National Alliance on Mental Illness New York City Metro are co-sponsoring a one-day conference on Friday, September 29 that The Mount Sinai Medical Center, Hatch Auditorium, Madison Avenue at East 100th Street, from 8 am to 5:00 pm.
A study led by researchers at Mount Sinai School of Medicine has shown that a cell-regulating gene overexpressed in about 30 to 50 percent of all breast cancers is associated with a better chance of survival and increased sensitivity to a cancer-fighting drug. The study appears in the September 6 issue of Journal of the National Cancer Institute.
According to a new study conducted by researchers at Mount Sinai School of Medicine, variations of a gene related to brain development and function"”OLIG2"”may play a causal role in the development of schizophrenia, a hereditary psychiatric disorder with no known biological cause.
According to a landmark study by researchers at Mount Sinai School of Medicine, heart failure (HF) patients who received routine follow-up by a nurse in addition to visits to a physician had fewer hospitalizations and functioned better than patients who received only usual care. The study appears in the August 15, 2006 issue of the Annals of Internal Medicine.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right